Antimicrobial peptides: a new class of antibioticsPELLEGRINI, Antonio.Current pharmaceutical design. 2002, Vol 8, Num 9, issn 1381-6128, 166 p.Serial Issue

Multiple activities in lantibiotics: Models for the design of novel antibiotics?PAG, U; SAHL, H.-G.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 815-833, issn 1381-6128Article

From innate immunity to de-novo designed antimicrobial peptidesSHAI, Yechiel.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 715-725, issn 1381-6128Article

Cationic peptides: Distribution and mechanisms of resistanceDEVINE, Deirdre A; HANCOCK, Robert E. W.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 703-714, issn 1381-6128Article

Molecular diversity in gene-encoded, cationic antimicrobial polypeptidesTOSSI, A; SANDRI, L.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 743-761, issn 1381-6128Article

Cathelicidin peptides as candidates for a novel class of antimicrobialsZANETTI, Margherita; GENNARO, Renato; SKERLAVAJ, Barbara et al.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 779-793, issn 1381-6128Article

Strategies for new antimicrobial proteins and peptides: Lysozyme and aprotinin as model moleculesIBRAHIM, Hisham R; AOKI, Takayoshi; PELLEGRINI, Antonio et al.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 671-693, issn 1381-6128Article

Host-defense antimicrobial peptides: Importance of structure for activitySITARAM, N; NAGARAJ, R.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 727-742, issn 1381-6128Article

Pro-rich antimicrobial peptides from animals: Structure, biological functions and mechanism of actionGENNARO, Renato; ZANETTI, Margherita; BENINCASA, Monica et al.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 763-778, issn 1381-6128Article

Development of short antimicrobial peptides derived from host defense peptides or by combinatorial librariesLEE, Keun-Hyeung.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 795-813, issn 1381-6128Article

Tailoring an antibacterial peptide of human lysosomal cathepsin G to enhance its broad-spectrum action against antibiotic-resistant bacterial pathogensSHAFER, W. M; KATZIF, S; BOWERS, S et al.Current pharmaceutical design. 2002, Vol 8, Num 9, pp 695-702, issn 1381-6128Article